The Enterprise Value as of December 2025 (TTM) for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is 36.59B

According to Hangzhou Tigermed Consulting Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 36.59B. This represents a change of -22.58% compared to the average of 47.26B of the last 4 quarters.

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Historical Enterprise Value (quarterly & annually)

How has HNGZY Enterprise Value performed in the past?

The mean historical Enterprise Value of Hangzhou Tigermed Consulting Co., Ltd. over the last ten years is 50.57B. The current 36.59B Enterprise Value has changed 7.14% with respect to the historical average. Over the past ten years (40 quarters), HNGZY's Enterprise Value was at its highest in in the June 2021 quarter at 158.64B. The Enterprise Value was at its lowest in in the June 2017 quarter at 11.30B.

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hangzhou Tigermed Consulting Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Average Enterprise Value

How has HNGZY Enterprise Value performed in the past?

The current Enterprise Value of Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) Enterprise Value vs. Peers

How is HNGZY’s Enterprise Value compared to its peers?

Hangzhou Tigermed Consulting Co., Ltd.’s Enterprise Value is greater than McKesson Europe AG (4.78B), greater than Dechra Pharmaceuticals PLC (4.83B), greater than Dechra Pharmaceuticals PLC (4.83B), less than Mediclinic International plc (392.13B), less than Sugi Holdings Co.,Ltd. (606.93B), greater than Galenica AG (5.38B), greater than Abcam plc (134.60M), less than IHH Healthcare Berhad (87.99B), less than Takara Bio Inc. (82.75B), greater than Ipsen S.A. (9.69B),

Build a custom stock screener for Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hangzhou Tigermed Consulting Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hangzhou Tigermed Consulting Co., Ltd. (HNGZY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hangzhou Tigermed Consulting Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.